(Q35193613)

7 August 2017

1 reference

title

Papillomavirus vaccines in clinical trials (English)

1 reference

7 August 2017

1 reference

Denise A Galloway

1

1 reference

7 August 2017

1 August 2003

1 reference

Lancet Infectious Diseases

7 August 2017

1 reference

7 August 2017

3

1 reference

7 August 2017

8

1 reference

7 August 2017

469-475

1 reference

Human papillomaviruses. Biochemical and biologic properties

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Postattachment neutralization of papillomaviruses by monoclonal and polyclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Infectious cycle of human papillomavirus type 11 in human foreskin xenografts in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Cervical intraepithelial neoplasia and human papillomavirus infection among Senegalese women seropositive for HIV-1 or HIV-2 or seronegative for HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Structure and transcription of human papillomavirus sequences in cervical carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Viral integration and fragile sites in human papillomavirus-immortalized human keratinocyte cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Small tumor virus genomes are integrated near nuclear matrix attachment regions in transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Loss of MHC class-I expression in cervical carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Natural history of cervicovaginal papillomavirus infection in young women.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Genital Human Papillomavirus Infection in Female University Students as Determined by a PCR-Based Method

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

A comparison of risk factors in juvenile‐onset and adult‐onset recurrent respiratory papillomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Human papillomavirus type 16 in infants: use of DNA sequence analyses to determine the source of infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Human papillomavirus infections in children: the potential role of maternal transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

High risk genital papillomavirus infections are not spread vertically

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

A survey of seroprevalence of human papillomavirus types 16, 18 and 33 among children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

New epidemiology of human papillomavirus infection and cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Recent trends in cervix uteri cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Identification of human papillomavirus seroconversions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Evaluation of Seroreactivity to Human Papillomavirus Type 16 Virus-like Particles in an Incident Case-Control Study of Cervical Neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Stability over time of serum antibody levels to human papillomavirus type 16.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Immunoglobulin-A and -G responses against virus-like particles (VLP) of human papillomavirus type 16 in women with cervical cancer and cervical intra-epithelial lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Prophylactic and therapeutic vaccination against a mucosal papillomavirus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Self-assembly of purified polyomavirus capsid protein VP1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Synthesis and assembly of infectious bovine papillomavirus particles in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Use of human papillomavirus type 6 capsids to detect antibodies in people with genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

The expressed L1 proteins of HPV-1, HPV-6, and HPV-11 display type-specific epitopes with native conformation and reactivity with neutralizing and nonneutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

HPV6b virus like particles are potent immunogens without adjuvant in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

A Phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles: correlation with competitive radioimmunoassay titer

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

A controlled trial of a human papillomavirus type 16 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Chimeric papillomavirus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Role of Conformational Epitopes Expressed by Human Papillomavirus Major Capsid Proteins in the Serologic Detection of Infection and Prophylactic Vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Immunological cross-reactivity to laboratory-produced HPV-11 virions of polysera raised against bacterially derived fusion proteins and synthetic peptides of HPV-6b and HPV-16 capsid proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: characterization of protein domains involved in DNA binding and capsid assembly

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Immunization with a pentameric L1 fusion protein protects against papillomavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Cervical cancer vaccines: progress and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Activity of HspE7, a novel immunotherapy, in patients with anogenital warts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Phase IIa safety and immunogenicity of a therapeutic vaccine, TA-GW, in persons with genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Partial characterization of viral DNA from human genital warts (condylomata acuminata)

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

Molecular cloning of viral DNA from human genital warts.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900720-5

7 January 2021

10.1016/S1473-3099(03)00720-5

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12901889